SENTI BIOSCIENCES INC (SNTI) Forecast, Price Target & Analyst Ratings
NASDAQ:SNTI • US81726A2096
0.9933 USD
+0.02 (+2.12%)
At close: Mar 10, 2026
0.9919 USD
0 (-0.14%)
Pre-Market: 3/11/2026, 8:03:44 AM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for SENTI BIOSCIENCES INC (SNTI).
Forecast Snapshot
Consensus Price Target
$11.73
+ 1,080.91% Upside
Next Earnings Forecast
Release DateMar 18, 2026
PeriodQ4 / 2025
EPS Estimate-$0.42
Revenue Estimate680.003K
ChartMill Buy Consensus
84.00%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
$11.73
Upside
+ 1,080.91%
From current price of $0.99 to mean target of $11.73, Based on 10 analyst forecasts
Low
$6.06
Median
$12.75
High
$15.75
Price Target Revisions
1 Month
0.00%
3 Months
2.22%
Price Target Summary
10 Wall Street analysts provided a forecast for the next 12 months for SNTI. The average price target is 11.73 USD. This implies a price increase of 1080.91% is expected in the next year compared to the current price of 0.9933.
The average price target has been revised upward by 2.22% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
84.00%
SNTI was analyzed by 10 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about SNTI.
In the previous month the buy percentage consensus was at a similar level.
SNTI was analyzed by 10 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2025-12-09 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-11-21 | Leerink Partners | Initiate | Outperform |
| 2025-10-14 | HC Wainwright & Co. | Initiate | Buy |
| 2025-08-08 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-06-12 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-06-06 | Laidlaw & Co. | Initiate | Buy |
| 2025-05-02 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-12-04 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-12-02 | Chardan Capital | Maintains | Buy -> Buy |
| 2023-08-15 | Chardan Capital | Reiterate | Buy -> Buy |
| 2023-05-11 | Chardan Capital | Maintains | Buy -> Buy |
| 2023-03-24 | Morgan Stanley | Maintains | Equal-Weight |
| 2023-03-23 | Chardan Capital | Maintains | Buy |
| 2023-01-30 | Chardan Capital | Maintains | Buy |
| 2023-01-27 | Morgan Stanley | Maintains | Equal-Weight |
| 2022-12-16 | JP Morgan | Initiate | Neutral |
| 2022-10-07 | Morgan Stanley | Initiate | Equal-Weight |
| 2022-09-29 | B of A Securities | Initiate | Buy |
| 2022-09-23 | Chardan Capital | Initiate | Buy |
Next Earnings Forecast Details
Next Earnings Details
Release DateMar 18, 2026
PeriodQ4 / 2025
EPS Estimate-$0.42
Revenue Estimate680.003K
Revenue Q2QN/A
EPS Q2Q37.20%
Number of Analysts6
Next Earnings Revisions
Revenue (1 Month)
0.00%
Revenue (3 Months)
0.00%
EPS (1 Month)
0.00%
EPS (3 Months)
5.17%
Next Earnings Summary
SNTI is expected to report earnings on 3/18/2026. The consensus EPS estimate for the next earnings is -0.42 USD and the consensus revenue estimate is 680.00K USD.
The next earnings revenue estimate has been revised downward by 0% in the past 3 months.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 2.761M 387.81% | 4.286M 55.23% | 2.561M -40.25% | 2.856M -100.00% | 680.003K | 1.7M 150.00% | -100.00% | 6.97M | 45.101M 547.07% | 155.99M 245.87% | 322.59M 106.80% | 343.33M 6.43% | 379.24M 10.46% | |
| EBITDA YoY % growth | -39.677M -64.43% | -60.686M -52.95% | -63.204M -4.15% | -64.26M 9.99% | -61.2M -7.58% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -40.446M -63.79% | -62.084M -53.50% | -66.765M -7.54% | -64.26M 9.05% | -67.304M -10.83% | -83.015M -23.34% | -99.763M -20.18% | -115.274M -15.55% | -106.902M 7.26% | -24.01M 77.54% | 112.9M 570.22% | N/A | N/A | |
| Operating Margin | -1,464.90% | -1,448.53% | -2,606.99% | -2,250.00% | -9,897.55% | -4,883.24% | N/A | -1,653.86% | -237.03% | -15.39% | 35.00% | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A 91.40% | -14.83 -848.26% | -2.70 81.81% | -1.44 46.79% | -1.64 -14.03% | -1.91 -16.51% | -1.70 10.96% | -0.23 86.49% | 2.21 1,064.44% | N/A | N/A |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.42 37.20% | -0.43 | -0.32 42.63% | -0.41 40.13% | -0.34 18.79% |
| Revenue Q2Q % growth | 680.003K | -100.00% | |||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -16.187M -0.12% | -18.768M -14.46% | -19.584M -16.59% | -20.4M -20.37% | -21.318M -31.70% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
23.63%
EPS Next 5 Year
13.52%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
-25.99%
Revenue Next 5 Year
73.65%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
SENTI BIOSCIENCES INC / SNTI Forecast FAQ
What is the average price target for SENTI BIOSCIENCES INC (SNTI) stock?
10 analysts have analysed SNTI and the average price target is 11.73 USD. This implies a price increase of 1080.91% is expected in the next year compared to the current price of 0.9933.
What is the next earnings date for SNTI stock?
SENTI BIOSCIENCES INC (SNTI) will report earnings on 2026-03-18, after the market close.
Can you provide the consensus estimates for SENTI BIOSCIENCES INC next earnings?
The consensus EPS estimate for the next earnings of SENTI BIOSCIENCES INC (SNTI) is -0.42 USD and the consensus revenue estimate is 680.00K USD.
Can you provide the analyst count for SENTI BIOSCIENCES INC stock?
The number of analysts covering SENTI BIOSCIENCES INC (SNTI) is 10.